ACHE and Alzheimer disease: Thus, the alleviating effect of the experimental combination on the increase in AChE activity in scopolamine-treated rats explains its memory improving effect, but, even more important, prompts its use not only in conditions of memory and learning deficits, but as part of multifactorial AD treatment as well.